Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Looking for participantsNCT06051695What this trial is testingEvaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionWho this might be right forSolid Tumor, AdultColorectal CancerNSCLC+17 more A2 Biotherapeutics Inc. 474
Early research (Phase 1)Looking for participantsNCT06756035What this trial is testingCT-95 in Advanced Cancers Associated With Mesothelin ExpressionWho this might be right forMesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more Context Therapeutics Inc. 70
Testing effectiveness (Phase 2)Study completedNCT00053885What this trial is testingPTK787/ZK 222584 in Treating Patients With Unresectable Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Alliance for Clinical Trials in Oncology 47
Large-scale testing (Phase 3)Ended earlyNCT01907100What this trial is testingNintedanib (BIBF 1120) in MesotheliomaWho this might be right forMesothelioma Boehringer Ingelheim 545
Early research (Phase 1)Active Not RecruitingNCT04491942What this trial is testingTesting the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial CancerWho this might be right forAdvanced Bile Duct CarcinomaAdvanced Breast CarcinomaAdvanced Cervical Carcinoma+31 more National Cancer Institute (NCI) 74
Not applicableEnded earlyNCT00898547What this trial is testingBiomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107Who this might be right forMalignant Mesothelioma Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Looking for participantsNCT05086692What this trial is testingA Beta-only IL-2 ImmunoTherapY StudyWho this might be right forAdvanced Solid TumorUnresectable Solid TumorClear Cell Renal Cell Carcinoma+34 more Medicenna Therapeutics, Inc. 115
Testing effectiveness (Phase 2)WithdrawnNCT03786419What this trial is testingAtezolizumab in Unresectable or Advaced Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma, AdvancedMalignant Pleural Mesothelioma, Unresectable Health Pharma Professional Research
Not applicableLooking for participantsNCT07126509What this trial is testingPartial Pleurectomy (Surgery) for Unresectable Pleural MesotheliomaWho this might be right forMesotheliomaMesothelioma; LungMesotheliomas Pleural+2 more University of Chicago 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06318286What this trial is testingStudy of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Hyogo Medical University 25
Large-scale testing (Phase 3)Active Not RecruitingNCT06097728What this trial is testingMEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural MesotheliomaWho this might be right forUnresectable Pleural Mesothelioma AstraZeneca 863
Large-scale testing (Phase 3)Study completedNCT02899299What this trial is testingStudy of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma PatientsWho this might be right forMesothelioma Bristol-Myers Squibb 605
Testing effectiveness (Phase 2)UnknownNCT02588131What this trial is testingTremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)Who this might be right forPleural MesotheliomaPeritoneal Mesothelioma Italian Network for Tumor Biotherapy Foundation 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02535312What this trial is testingMethoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or CarboplatinWho this might be right forAdvanced Malignant Solid NeoplasmAdvanced Peritoneal Malignant MesotheliomaAdvanced Pleural Malignant Mesothelioma+4 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT02611037What this trial is testingTransarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural MesotheliomaWho this might be right forMalignant Pleural MesotheliomaMesothelioma H. Lee Moffitt Cancer Center and Research Institute 34
Testing effectiveness (Phase 2)Study completedNCT02293005What this trial is testingPhase II Trial of Alisertib (MLN8237) in Salvage Malignant MesotheliomaWho this might be right forLung CancerMesothelioma M.D. Anderson Cancer Center 28
Testing effectiveness (Phase 2)Ended earlyNCT02357147What this trial is testingStudy of the Safety and Efficacy of Amatuximab in Combination With Pemetrexed and Cisplatin in Subjects With Unresectable Malignant Pleural Mesothelioma (MPM)Who this might be right forMesothelioma, Malignant Morphotek 124
Testing effectiveness (Phase 2)UnknownNCT01649024What this trial is testingA Clinical Study With Tremelimumab as Monotherapy in Malignant MesotheliomaWho this might be right forMalignant Mesothelioma Azienda Ospedaliera Universitaria Senese 29
Early research (Phase 1)WithdrawnNCT02639767What this trial is testingConcurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural MesotheliomaWho this might be right forMalignant Pleural Mesothelioma Memorial Sloan Kettering Cancer Center